Stay informed, prepared, and inspired

Explore the scientific agenda, speaker profiles, abstract submissions, CME details, exhibitor opportunities, and exclusive announcements. The site offers seamless access to one of the most anticipated hematology conferences. Expect regular updates, live session highlights, early-bird offers, and ongoing speaker reveals. It’s your go-to hub for professionals dedicated to advancing hematology.

500

+

Attendees expected
Healthcare professionals, researchers, and students

8

+

Sessions
International collaboration and networking

45

+

Talks
Interactive talks and hands-on workshop

40

+

Expert speakers
Leading voices in pediatric medicine

It is a privilege to welcome you to the 1st International Conference of Classical Hematology 2026, taking place on March 27-29th, 2026, in Doha, Qatar. This landmark event offers an exceptional platform for hematologists to enhance their knowledge and advance their clinical practices.

For the first time in the Middle East, renowned regional and international speakers will come together to establish a groundbreaking platform, presenting an extensive agenda focused on key advancements and innovations in the field of classical hematology.

The conference serves as a prime opportunity to engage with rapidly evolving developments in hematology, explore novel treatment options for patients, and refine professional methodologies. Moreover, it provides a unique setting for networking, fostering collaborations, and building connections with leading experts and key stakeholders.

We eagerly anticipate welcoming our colleagues from across the globe to Doha, where they can experience the city's charm and the renowned hospitality of Qatar.

Prof. Mohamed A. Yassin

Chairman - International Conference of Classical Hematology,
Chairman - Hematology Academy,
Senior Consultant Hematologist
Qatar

Abdulhakim Al Rawas

Abdulhakim Al Rawas

President, Omani Society of Hematology
Senior Consultant, Pediatric Hematology/Oncology
Sultan Qaboos University Hospital
Oman
Ahmad Tarawah

Ahmad Tarawah

President, Madinah Hereditary Blood Disorders Society
President, Middle East and North Africa Hematology League
Saudi Society of Blood Disorders
Saudi Arabia
Asma Al Olama

Asma Al Olama

President, Emirates Society of Haematology
Consultant Hematologist
Dubai Hospital
United Arab Emirates
Mona Al Rasheed

Mona Al Rasheed

Consultant, head of clinical hematology unit
Adan Hospital, MOH
Kuwait
Mohamed A. Yassin

Mohamed A. Yassin

Head - Scientific Committee
Chairman - Hematology Academy
Senior Consultant Hematologist
Doha, Qatar
Biree Andemariam

Biree Andemariam

Professor of Medicine
American Red Cross Endowed Chair in Transfusion Medicine
University of Connecticut School of Medicine
United States
Drew Provan

Drew Provan

Consultant Haematologist
Chase Lodge Hospital
United Kingdom
Hanny Al-Samkari

Hanny Al-Samkari

Associate Professor of Medicine,
Harvard Medical School, Massachusetts General Hospital
United States
Honar Cherif

Honar Cherif

Chairman of Hematology & BMT
Clinical Professor, College of Medicine, Qatar University
Hamad Medical Corporation
Qatar
Khaled Musallam

Khaled Musallam

Group Chief Research Officer
Burjeel Holdings
United Arab Emirates
Mozah AlMarshoodi

Mozah AlMarshoodi

Acting Head of Medical Department
Sheikh Khalifa Hospital, Fujairah
United Arab Emirates
Muna Al Tarshi

Muna Al Tarshi

Senior Consultant - Hematology and Bone Marrow Transplant
The Royal Hospital
Oman
Salwa Ibrahim Hindawi

Salwa Ibrahim Hindawi

Consultant Haematology & Transfusion Medicine
President of Saudi Friends for Thalassaemia & SCA Society
President & Scientific Officer of Saudi Society of Transfusion Medicine & Services
Jeddah, Saudi Arabia

Who Should Attend?

  • Hematologists
  • Oncologists
  • Fellows, residents, and medical students
  • Clinical Pharmacists
  • Nurse Practitioners
  • Clinical Nurse Educators
  • Registered Nurses / General Nursing Staff
  • Infection Prevention and Control Professional
  • Quality Management and Patient Safety Officers
  • Case Managers
  • Academics and Medical Faculty
  • Allied Health Professionals

*Currently being updated!

We've streamlined the key dates below to help you prepare for the conference and make the most of this premier hematology event. Be sure to mark them in your calendar and join us!

Oct 8

Online Registration Open (Early Bird)

Dec 23

Abstract submissions opens (Oral/Poster)

Jan 9

Program Topics Announced

Jan 9

Invited Faculty Announced

Feb 2

Abstract Submission Closes

Feb 26

Early Bird Registration Closes

Feb 27

Standard Registration Opens

Mar 2

Final Program

Mar 2

CME Announcement

Mar 2

Author Notifications (Oral/Poster)

Mar 27

ICCH Goes live

Mar 29

Closing Ceremony

We are delighted to welcome you to the 1st International Conference of Classical Hematology 2026 — a landmark gathering dedicated to showcasing the latest advancements, research, and innovations shaping the field of Hematology. 

Join us for a dynamic and insightful scientific program designed to foster collaboration, inspire discovery, and advance excellence in Hematology practice and research.

Session highlights at a glance

  • Advances in the Diagnosis and Management of Hemolytic Anemias
  • Thalassemia Management
  • Hemophagocytic Lymphohistiocytosis
  • Thrombosis
  • Latest Management on Hemophilia
  • Updates on ITP
  • Paroxysmal Nocturnal Hemoglobinuria 
  • Updates on TTP
  • Sickle Cell Management

CME Accreditation

Instructions for Claiming CME Certificates:

  • Post the event, registered attendees will receive an online evaluation survey to their registered email address.
  • Once the survey is completed, you will automatically receive the CME Certificate by email.
  • Please ensure that the email address provided at the time of registration is accurate.

Disclosure and Resolution of Personal Conflicts of Interest

This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support.

Session Attendance Scanning :

  • Attendance to the sessions will be monitored through scanning of the barcode on your conference badge at the entrance of the session hall.
  • CME credits will be awarded in accordance with session attendance.
We are proud to present the distinguished speakers and faculty of the 1st International Conference of Classical Hematology (ICCH) 2026. This accomplished group of experts will share their insights and perspectives, shaping ICCH 2026 into an unmissable event for professionals committed to advancing hematology.

The conference features renowned leaders from leading institutions around the world, delivering a scientific program designed to inspire innovation, enhance learning, and drive meaningful progress in hematology.
Abdullah Al Zayed

Abdullah Al Zayed

Consultant Internist and Hematologist

Qatif Health Network, Saudi Arabia

Bio
Dr. Abdullah Al Zayed is a consultant hematologist and is the former head of the inherited blood disorders center at Qatif Central Hospital, He is the founder and first program director of hematology fellowship at Qatif Health Network. He championed the sickle cell disease pathway in the eastern health cluster for adult patients. He was trained in Ireland and gained the MRCPI & Hematology fellowship by RCPI. He is the hematology service leader & the manager of the hematology program in the E1 cluster of the Ministry of Health- Hematology Development program project.
Abdulrahman Al-Mashdali

Abdulrahman Al-Mashdali

Bio
Afaf Al Battah

Afaf Al Battah

Consultant

Bio
Ahmad Tarawah

Ahmad Tarawah

President, Madinah Hereditary Blood Disorders Society

President, Middle East and North Africa Hematology League

Saudi Arabia

Bio
Professor Ahmad M. Tarawah is a pediatric hematologist and oncologist based in Madinah, Saudi Arabia. He serves as a consultant at King Salman Medical City and chairs the Madinah Hereditary Blood Disorders Society. Holding a medical degree from King Abdulaziz University (1990), he completed pediatric training in Edinburgh and earned his Arab Board certification in 1997. He further specialized in pediatric hematology/oncology at King Faisal Specialist Hospital, obtaining a fellowship in 2001. Professor Tarawah has authored over 140 publications, contributed to national treatment guidelines, and founded multiple hematology societies and charitable organizations. His work focuses on hemophilia, sickle cell anemia, and bleeding disorders.
Ali Taher

Ali Taher

Professor of Internal Medicine – Hematology Oncolog

Director – Naef K. Basile Cancer Institute

Lebanon

Bio
Ali T. Taher is a tenured Professor of Medicine in Hematology & Oncology at the American University of Beirut Medical Center, Director of the Naef K. Basile Cancer Institute, and Associate VP for Academic Centers. A globally recognized expert in anemia and thalassemia, he has published over 500 papers, delivered 200+ invited lectures, and received numerous awards, including the EHA Education and Mentoring Award, KFAS Prize, and Lebanon’s National Cedar Medal.
Asma Sultan Al Olama

Asma Sultan Al Olama

President, Emirates Society of Haematology

Consultant Hematologist, Dubai Hospital

United Arab Emirates

Bio
Awni Alshurfa

Awni Alshurfa

Bio
Biree Andemariam

Biree Andemariam

Professor of Medicine American Red Cross Endowed Chair in Transfusion Medicine

Chair in Transfusion Medicine at the University of Connecticut School of Medicine

Bio
Dr. Biree Andemariam is Professor of Medicine and the American Red Cross Endowed Chair in Transfusion Medicine at the University of Connecticut School of Medicine. She directs the Connecticut Bleeding Disorders Center and founded the New England Sickle Cell Institute. Board-certified in Internal Medicine, Hematology, and Oncology, Dr. Andemariam trained at NewYork-Presbyterian/Weill Cornell and completed the NHLBI PRIDE Research Fellowship. She serves as Chief Medical Officer of the Sickle Cell Disease Association of America.
David Kuter

David Kuter

Professor of Medicine at Harvard Medical School

Distinguished Physician at Massachusetts General Hospital

USA

Bio
Prof. David J. Kuter is Distinguished Physician at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. A former Chief of Hematology at MGH, he is a global leader in thrombopoietin biology and immune thrombocytopenia. A Rhodes Scholar, he has authored over 350 publications, delivered 700+ international lectures, and received numerous prestigious teaching and research awards in hematology.
Drew Provan

Drew Provan

Emeritus Reader in Haematology

Barts & The London School of Medicine, Queen Mary University of London

UK

Bio
Dr. Drew Provan is Emeritus Reader in Autoimmune Haematology at Barts and The London School of Medicine and Dentistry. He originally studied molecular genetics before training in medicine, and later undertook research at the Dana–Farber Cancer Institute in Boston as an MRC Travelling Fellow. Dr Provan is a leading authority in immunohaematology, with a major focus on immune thrombocytopenia, neutropenia and haemolytic anaemia. He helped establish the UK ITP Registry and is a senior author of the International Consensus Guidelines for the diagnosis and management of ITP in adults and children. He has published extensively in the field and is author of several well-known medical texts, including Molecular Haematology, the Oxford Handbook of Clinical Haematology, and the ABC of Clinical Haematology.
Flora Peyvandi

Flora Peyvandi

Director of the Department of Pathophysiology and Transplantation, Milan, Italy

Director of the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

Bio
Dr. Flora Peyvandi is Professor of Internal Medicine at the University of Milan and Director of the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center at Milan Policlinic Hospital, Italy. Her research focuses on coagulation disorders, microvascular dysfunction, and innovative diagnostic and therapeutic strategies. She has held leading roles in international scientific societies, including President of the International Society on Thrombosis and Haemostasis, and currently serves as an advisor to the European Medicines Agency and the Italian Ministry of Health.
Gerry Dolan

Gerry Dolan

Consultant Haematologist and Hemophilia Centre Director

St Thomas’ Comprehensive Care Centre, London, UK

Bio
Dr. Gerry Dolan is a consultant haematologist and haemophilia centre director at St Thomas’ Comprehensive Care Centre, London, UK, and former centre director at Nottingham University Hospitals, Nottingham, UK. He is former chairman of the UK Haemophilia Centre Directors and president of the British Society for Haemostasis & Thrombosis. He has been an active participant in collaborative European initiatives in haemophilia and has chaired initiatives such as the ADVANCE group and the European Haemophilia Therapy Standardisation Board. His interests include novel agents in the treatment of haemophilia, gene therapy and clinical outcomes.
Hadeel Saleh

Hadeel Saleh

Consultant Hematology,Oncology, Hemostasis and Thrombosis Pediatric, NBK Specialized Children’s Hospital

Kuwait Hematology Association

Kuwait

Bio
Hani Osman

Hani Osman

Medicine Hematology Oncology, Consultant Physician

Tawam Hospital

Bio
Hanny Al- Samkari

Hanny Al- Samkari

Associate Professor of Medicine

Harvard Medical School, Massachusetts General Hospital United States

United States

Bio
Hanny Al-Samkari, M.D. is a classical hematologist and leading international clinical investigator in hemostasis, platelet disorders, and hemolytic anemias. His focus is on the development of novel therapeutics in hereditary hemorrhagic telangiectasia, immune thrombocytopenia, chemotherapy-induced thrombocytopenia and hemolytic anemia. He serves as global principal investigator for many ongoing studies in these areas.
Hind Salama

Hind Salama

Consultant Adult Hematology

KAMC Riyadh, Saudi Arabia

Bio
Dr. Hind Salama is a Consultant Adult Hematologist at King Abdulaziz Medical City, Riyadh, and Assistant Professor at King Saud bin Abdulaziz University for Health Sciences. She holds an MBBS from Gezira University and MRCP (UK), with fellowship training in hematology and bone marrow transplantation. She leads adult acute lymphoblastic leukemia and histiocytic clinics and established Saudi Arabia’s first adult histiocytic clinic. Dr. Salama has received multiple research awards, authored 46 publications, and is an ASH Choosing Wisely Champion.
Honar Cherif

Honar Cherif

Senior Consultant Hematologist Chairman of Dept of Hematology & BMT National Center for Cancer Care & Research

Hamad Medical Corporation

Qatar

Bio
Dr. Honar Cherif is Associate Professor and Senior Consultant Hematologist, currently Chair of Hematology and Bone Marrow Transplantation at NCCCR, Hamad Medical Corporation, Doha. He is Professor of Hematology at Qatar University and has extensive leadership experience in Sweden at Uppsala University Hospital. Board-certified in Hematology and Internal Medicine, Dr. Cherif has authored over 50 publications, led multiple clinical trials, and mentors students and specialists in hematology worldwide.
Jaffer Altooq

Jaffer Altooq

Chief Resident at the Hereditary Blood Disorder Centre

Salmaniya Medical Complex

Bahrain

Bio
Dr. Jaffer Abduljabbar Altooq is Chief Resident at the Hereditary Blood Disorder Centre, Salmaniya Medical Complex, Bahrain. He leads the Sickle Cell Disease team and serves on the SCD management board and MOH transfusion committee. With extensive experience in hematology and oncology, he coordinates training programs and has published research on sickle cell disease. He also volunteers as Deputy Chairman of the Bahrain Sickle Cell Society and with local charitable organizations.
Jan-Inge Henter

Jan-Inge Henter

Professor, Senior

Karolinska Institutet

Bio
Khaled Musallam

Khaled Musallam

Group Chief Research Officer

Burjeel Holdings United Arab Emirates

Bio
Prof. Khaled Musallam MD PhD is currently the Group Chief Research Officer at Burjeel Holdings in Abu Dhabi, UAE where he founded the clinical research function and operations across the Group’s large hospital network. He is also Chief of Cell & Gene and Hematology, Director of the Thalassemia & Sickle Cell Center, and Founding Director of the Center for Research on Rare Blood Disorder (CR-RBD) at Burjeel Cancer Institute located in the Group’s flagship hospital, Burjeel Medical City. He is also Global Research Lead at Burjeel Institute for Global Health in New York, Adjunct Professor at Khalifa University in Abu Dhabi, and Adjunct Professor at Weill Cornel Medicine in New York. He has authored over 230 articles on hemoglobin disorders with practice-changing papers in leading international peer-reviewed journals including the New England Journal of Medicine, Lancet, Nature, Blood, among others. His h-index is 65. He is also editor of the Thalassaemia International Federation management guidelines. Prof. Musallam was the recipient of the 2025 European Haematology Association Clinical Excellence Award.
Lan-Lan Smith

Lan-Lan Smith

Editor-in-Chief

The Lancet Group, London

UK

Bio
Lulwah Altourah

Lulwah Altourah

Senior Specialist

Adan Hospital

Bio
Maria Domenica Cappellini

Maria Domenica Cappellini

Professor of Internal Medicine

University of Milan, Fondazione IRCCS Policlinico Hospital Milan, Italy

Italy

Bio
Dr. Cappellini has been active in the fields of thalassaemia, haemoglobinopathies, and the heme biosynthetic pathway for over 40 years. She focused on the phenotypic expression of thalassaemia major and intermedia and evaluated the genotype-phenotype relationship, taking into account the co-inheritance of modifier genes. She identified the mechanisms underlying the thrombotic risks in thalassaemia. She studies in vitro molecules capable of inducing fetal hemoglobin in view of therapeutic application. She is involved in gene therapy development for thalassemia.
Mozah Almarshoodi

Mozah Almarshoodi

Chair of Medical Institute

Sheikh Khalifa Hospital, Fujairah

United Arab Emirates

Bio
Muhammad Yassin

Muhammad Yassin

Head - Scientific Committee Chairman - Hematology Academy

Senior Consultant Hematologist Doha, Qatar

United Arab Emirates

Bio
Muna Al Rasheed

Muna Al Rasheed

Consultant, Head of clinical hematology unit

Adan Hospital, MOH Kuwait

Bio
She is a consultant and head of clinical haematology unit adan hospital MOH kuwait. She is also the Head of examinations committee for clinical hematology fellowship KIMS , she is a Graduate of faculty of medicine kuwait university , done her Internship in internal medicine university of Toronto and has a Fellowship in clinical hematology McMaster university as well as a Number of publications in itp / ttp/ pnh and other benign hematology
Salam Al Kindi

Salam Al Kindi

Professor & Senior Consultant Hematologist, Director of National Hematology anc BMT center

University medical city Muscat Oman

Oman

Bio
Salwa Hindawi

Salwa Hindawi

Consultant Haematology & Transfusion Medicine President of Saudi Friends for Thalassaemia & SCA Society

President & Scientific Officer of Saudi Society of Transfusion Medicine & Services Jeddah, Saudi Arabia

Bio
Dr. Hind Abdin Ahmed Salama is a consultant adult hematologist at King Abdulaziz Medical City, Riyadh, and Assistant Professor at King Saud bin Abdulaziz University for Health Sciences. She earned her MBBS from Gezira University, Sudan, MRCP-UK, and completed an SFH hematology and bone marrow transplant fellowship. She leads acute lymphoblastic leukemia and adult histiocytic clinics and initiated the first adult histiocytic clinic in Saudi Arabia. Dr. Salama has 46 publications, received multiple national and international research awards, and was recognized by the ECD Global Alliance as a referral expert and center.
Shehab Fareed

Shehab Fareed

Consultant Hematology

Hamad Medical Corporation - HMC

Qatar

Bio

Scientific Voices

Oral and poster presentations provide a valuable platform to share your research with a focused and engaged audience, enabling direct feedback, discussion, and collaboration. These formats will help raise your profile within the scientific community, opening doors to future opportunities, and career advancement.

We encourage our colleagues from around the world to take part and join our list of speakers by contributing an abstract to within the oral and poster presentation sessions.

Suggested Topics :

  • Advances in the Diagnosis and Management of Hemolytic Anemias 
  • Hemophagocytic Lymphohistiocytosis
  • Latest Management on Hemophilia
  • Paroxysmal Nocturnal Hemoglobinuria 
  • Sickle Cell Management
  • Thalassemia Management
  • Thrombosis
  • Updates on ITP
  • Updates on TTP

Guidelines for submitting an abstract :

A special criterion for accepting abstracts will be their topic as well as structure, content and degree of innovation. The scientific committee will accept abstracts based on their relevance and quality, structure, content and degree of innovation.

  • Please note that a maximum of 300 words is permitted. The titles and the names of the authors are excluded from this number and have to be entered separately. Tables should not be included in the abstract body.
  • Methods section should include type of statistical analysis done if applicable to the study.
  • Statements like “Results will be discussed” are not acceptable and may lead to a rejection of the abstract.

Abstract Delivery Notification

Authors will be notified about the delivery of their abstract by e-mail immediately. In case you do not receive confirmation within 24 hours, please check your spam folder. In case of no confirmation e-mail,
please contact : ipccconference@meetingmindsexperts.com

Register Now

Get ready to mark your calendars for 1st International Conference of Classical Hematology 2026.

Early Bird Fees

Physician
USD 350
Allied Health
USD 250
Nurse
USD 250
Resident
USD 200
Student
USD 100
Register

What's Included

  • Access to Session Halls
  • Access to Exhibition Halls
  • Lunch
  • Final Program
  • Coffee Breaks
  • Mobile App
  • Workshops

*All rates exclusive of 5% VAT

Venue Info

Hilton Doha

Hilton Doha is a prestigious 5-star hotel that blends contemporary elegance with Qatari hospitality. Ideally located on the city’s waterfront, this luxurious hotel offers spacious rooms and suites, each with breathtaking views of the Arabian Gulf. Known for its exceptional service, Hilton Doha features world-class dining options, a serene spa, and a private beach. The hotel also boasts state-of-the-art meeting and event facilities, making it the perfect choice for both business and leisure travelers seeking refined comfort and convenience in the heart of Doha.

Frequently Asked Questions

Comprehensive answers for attendees

Find information on registration, session details, and networking opportunities. We're here to ensure you have a seamless conference experience.

Agreement
Forms of Payments
Important Information
Cancellation

Need Assistance?